Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Clinical Significance of Addition of Cytarabine or Thiotepa to TBI/CY Regimen.

Takayoshi Tachibana, MD, Masatsugu Tanaka, MD, Maki Hagihara, MD, Rika Ohshima, MD, Etsuko Yamazaki, MD, Hideyuki Koharazawa, MD, Jun Taguchi, MD, Naoto Tomita, MD, Katsumichi Fujimaki, MD, Rika Sakai, MD, Hiroyuki Fujita, Shin Fujisawa, MD, Atsuo Maruta, MD, Yoshiaki Ishigatsubo, MD, Heiwa Kanamori, MD, PhD

Blood (2012) 120 (21): 3028.

https://doi.org/10.1182/blood.V120.21.3028.3028

Published: 2012

Journal Articles

Multicenter Validation of the Scoring System of Pre-Transplant Serum Ferritin and Disease Risk in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation

Takayoshi Tachibana, MD, Masatsugu Tanaka, MD, Estuko Yamazaki, MD, Ayumi Numata, MD, Hirotaka Takasaki, MD, Hideyuki Kuwabara, MD, Katsumichi Fujimaki, MD, Rika Sakai, MD, Hiroyuki Fujita, Shin Fujisawa, MD, Atsuo Maruta, MD, Yoshiaki Ishigatsubo, MD, Heiwa Kanamori, MD

Blood (2011) 118 (21): 2032.

https://doi.org/10.1182/blood.V118.21.2032.2032

Published: 2011

Journal Articles

Prognostic Impact of Posttransplantation Serum Ferritin In Allogeneic Stem Cell Transplantation for Leukemia or Myelodysplastic Syndrome.

Heiwa Kanamori, MD, PhD, Takayoshi Tachibana, MD, Ayumi Numata, MD, Masatsugu Tanaka, MD, PhD, Yoshiaki Ishigatsubo, MD, PhD, Atsuo Maruta, MD, PhD

Blood (2010) 116 (21): 3444.

https://doi.org/10.1182/blood.V116.21.3444.3444

Published: 2010

Journal Articles

Risk Factors for Developing Human Herpes Virus-6 Encephalitis and Clinical Significance of Antiviral Therapy In Early Phase After Allogeneic Hematopoietic Stem Cell Transplantation.

Ayumi Numata, MD, Masatsugu Tanaka, MD, Takayoshi Tachibana, MD, Yoshiaki Ishigatsubo, MD, Atsuo Maruta, MD, Heiwa Kanamori, MD

Blood (2010) 116 (21): 4538.

https://doi.org/10.1182/blood.V116.21.4538.4538

Published: 2010

Journal Articles

Elevated Serum Ferritin Predicts the Delay of Engraftment and High Incidence of Blood Stream Infection within 100 Days After Allogeneic Hematopoietic Stem Cell Transplantation.

Heiwa Kanamori, MD, Takayoshi Tachibana, MD, Hirotaka Takasaki, MD, Masatsugu Tanaka, MD, Yoshiaki Ishigatsubo, MD, Atsuo Maruta, MD

Blood (2009) 114 (22): 1135.

https://doi.org/10.1182/blood.V114.22.1135.1135

Published: 2009

Journal Articles

Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes

Yachiyo Kuwatsuka, Koichi Miyamura, Ritsuro Suzuki, Masaharu Kasai, Atsuo Maruta, Hiroyasu Ogawa, Ryuji Tanosaki, Satoshi Takahashi, Kyuhei Koda, Kazuhiro Yago, Yoshiko Atsuta, Takashi Yoshida, Hisashi Sakamaki, Yoshihisa Kodera

Blood (2009) 113 (9): 2096–2103.

https://doi.org/10.1182/blood-2008-03-145862

Published: 2009

Includes: Supplemental data

Journal Articles

Late Pulmonary Dysfunction in Long-Term Survivors after allogeneic Hematopoietic Stem Cell Transplantation with Intensified Conditioning Regimen Including Thiotepa, Cyclophosphamide, and Total Body Irradiation.

Satomi Ito, Maki Hagihara, Kenji Motohashi, Atsuo Maruta, Yoshiaki Ishigatsubo, Heiwa Kanamori, MD, PhD

Blood (2008) 112 (11): 2137.

https://doi.org/10.1182/blood.V112.11.2137.2137

Published: 2008

Journal Articles

Clinical Feature and Prognosis of 60 Patients Presenting Graft Failure (GF) after Allogeneic Stem Cell Transplantation (SCT).

Maki Hagihara, Heiwa Kanamori, Fumiaki Yoshiba, Nobuyuki Aotsuka, Masatsugu Tanaka, Takehiko Mori, Chiaki Nakaseko, Shin Fujisawa, Tohru Sakura, Taeko Uehara, Nobutaka Kawai, Takafumi Matsushima, Shinichiro Machida, Hisashi Makita, Atsuo Maruta, Hisashi Sakamaki

Blood (2007) 110 (11): 4929.

https://doi.org/10.1182/blood.V110.11.4929.4929

Published: 2007

Journal Articles

Air Leak Syndrome (ALS) Following Allogeneic Stem Cell Transplantation (SCT): A Report of 22 Patients from Kanto Study Group for Cell Therapy (KSGCT) in Japan.

Rika Sakai, Heiwa Kanamori, Shinichiro Okamoto, Fumiaki Yoshiba, Katsumichi Fujimaki, Tohru Sakura, Shin Fujisawa, Nobutaka Kawai, Chiaki Nakaseko, Masahiro Onoda, Takafumi Matsushima, Atsuo Maruta, Hisashi Sakamaki

Blood (2007) 110 (11): 5022.

https://doi.org/10.1182/blood.V110.11.5022.5022

Published: 2007

Journal Articles

Factors Associated with Relapse-Free Survival in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Imatinib-Combined Chemotherapy.

Masamitsu Yanada, MD, Jin Takeuchi, MD, Isamu Sugiura, MD, Hideki Akiyama, MD, Noriko Usui, MD, Fumiharu Yagasaki, MD, Kazuhiro Nishii, MD, Yasunori Ueda, MD, Makoto Takeuchi, MD, Shuichi Miyawaki, MD, Atsuo Maruta, MD, Hiroto Narimatsu, MD, Yasushi Miyazaki, MD, Shigeki Ohtake, MD, Itsuro Jinnai, MD, Keitaro Matsuo, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2007) 110 (11): 2813.

https://doi.org/10.1182/blood.V110.11.2813.2813

Published: 2007

Journal Articles

Remission Induction Treatment for 6 Patients of Jehovah’s Witnesses with De Novo Acute Leukemia.

Hiroyuki Fujita, MD, Mai Iguchi, MD, Takayoshi Tachibana, MD, Sachiya Takemura, MD, Jun Taguchi, MD, Masatsugu Tanaka, MD, Atsuo Maruta, MD, Yoshiaki Ishigatsubo, MD

Blood (2006) 108 (11): 4553.

https://doi.org/10.1182/blood.V108.11.4553.4553

Published: 2006

Journal Articles

Unrelated Donor Marrow Transplantation for Acute Lymphoblastic Leukemia in Japan. A Japan Marrow Donor Program Experience between 1993 and 2003.

Masahiro Tsuchida, MD, Hiroshi Sao, MD, Hisashi Sakamaki, MD, Keisei Kawa, MD, Yoshinobu Kanda, MD, Koji Kato, MD, Masamichi Hara, MD, Mutsuo Ishii, MD, Akira Kikuchi, MD, Jun Okamura, MD, Atsuo Maruta, MD, Yoichi Takaue, MD, Masaharu Kasai, MD, Hiromasa Yabe, MD, Yasuo Morishima, MD, Shunichi Kato, MD, Yoshihisa Kodera, MD

Blood (2005) 106 (11): 442.

https://doi.org/10.1182/blood.V106.11.442.442

Published: 2005

Journal Articles

Risk Factors and Outcome of Chronic GVHD: Analysis of 5,660 Patients Undergoing Unrelated Bone Marrow Transplantation through the Japan Marrow Donor Program.

Chiaki Nakaseko, Miki Nishimura, Shinnichi Ozawa, Ryuko Cho, Chikako Ohwada, Atsuo Maruta, Hisashi Sakamaki, Hiroshi Sao, Shin-ichiro Mori, Shinichiro Okamoto, Koichi Miyamura, Shunichi Kato, Tadakazu Kawase, Yasuo Morishima, Yoshihisa Kodera

Blood (2005) 106 (11): 139.

https://doi.org/10.1182/blood.V106.11.139.139

Published: 2005

Journal Articles

Retrospective Analysis of 23 Cases with Human Herpesvirus-6 Associated Encephalitis after Allogeneic Hematopoietic Cell Transplantation.

Blood (2004) 104 (11): 5067.

https://doi.org/10.1182/blood.V104.11.5067.5067

Published: 2004

Journal Articles

A Possible Association between the Presence of Interleukin-4-Secreting Cells and a Reduction in the Risk of Acute Graft-Versus-Host Disease.

Maki Takabayashi, MD, Heiwa Kanamori, MD, Hirotaka Takasaki, MD, Satoshi Yamaji, MD, Hideyuki Koharazawa, MD, Jun Taguchi, MD, Naoto Tomita, MD, Katsumichi Fujimaki, MD, Hiroyuki Fujita, MD, Shin Fujisawa, MD, Atsuo Maruta, MD, Yoshiaki Ishigatsubo, MD

Blood (2004) 104 (11): 4968.

https://doi.org/10.1182/blood.V104.11.4968.4968

Published: 2004

Journal Articles

Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000)

Yoshinobu Kanda, Shigeru Chiba, Hisamaru Hirai, Hisashi Sakamaki, Tohru Iseki, Yoshihisa Kodera, Takahiro Karasuno, Shinichiro Okamoto, Noriyuki Hirabayashi, Koji Iwato, Atsuo Maruta, Yoshihiro Fujimori, Tatsuo Furukawa, Shin Mineishi, Keitaro Matsuo, Nobuyuki Hamajima, Masahiro Imamura

Blood (2003) 102 (4): 1541–1547.

https://doi.org/10.1182/blood-2003-02-0430

Published: 2003

Journal Articles

Clinical Significance of Inhibitors in Acquired von Willebrand Syndrome

Hiroshi Mohri, Shigeki Motomura, Heiwa Kanamori, Michio Matsuzaki, Shin-ichiro Watanabe, Atsuo Maruta, Fumio Kodama, Takao Okubo

Blood (1998) 91 (10): 3623–3629.

https://doi.org/10.1182/blood.V91.10.3623

Published: 1998

NARROW

Clinical Significance of Addition of Cytarabine or Thiotepa to TBI/CY Regimen.

Multicenter Validation of the Scoring System of Pre-Transplant Serum Ferritin and Disease Risk in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation

Prognostic Impact of Posttransplantation Serum Ferritin In Allogeneic Stem Cell Transplantation for Leukemia or Myelodysplastic Syndrome.

Risk Factors for Developing Human Herpes Virus-6 Encephalitis and Clinical Significance of Antiviral Therapy In Early Phase After Allogeneic Hematopoietic Stem Cell Transplantation.

Elevated Serum Ferritin Predicts the Delay of Engraftment and High Incidence of Blood Stream Infection within 100 Days After Allogeneic Hematopoietic Stem Cell Transplantation.

Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes

Late Pulmonary Dysfunction in Long-Term Survivors after allogeneic Hematopoietic Stem Cell Transplantation with Intensified Conditioning Regimen Including Thiotepa, Cyclophosphamide, and Total Body Irradiation.

Clinical Feature and Prognosis of 60 Patients Presenting Graft Failure (GF) after Allogeneic Stem Cell Transplantation (SCT).

Air Leak Syndrome (ALS) Following Allogeneic Stem Cell Transplantation (SCT): A Report of 22 Patients from Kanto Study Group for Cell Therapy (KSGCT) in Japan.

Factors Associated with Relapse-Free Survival in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Imatinib-Combined Chemotherapy.

Remission Induction Treatment for 6 Patients of Jehovah’s Witnesses with De Novo Acute Leukemia.

Unrelated Donor Marrow Transplantation for Acute Lymphoblastic Leukemia in Japan. A Japan Marrow Donor Program Experience between 1993 and 2003.

Risk Factors and Outcome of Chronic GVHD: Analysis of 5,660 Patients Undergoing Unrelated Bone Marrow Transplantation through the Japan Marrow Donor Program.

Retrospective Analysis of 23 Cases with Human Herpesvirus-6 Associated Encephalitis after Allogeneic Hematopoietic Cell Transplantation.

A Possible Association between the Presence of Interleukin-4-Secreting Cells and a Reduction in the Risk of Acute Graft-Versus-Host Disease.

Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000)

Clinical Significance of Inhibitors in Acquired von Willebrand Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only